메뉴 건너뛰기




Volumn 8, Issue , 2015, Pages 985-990

Impact of beta-blockers on prostate cancer mortality: A meta-analysis of 16,825 patients

Author keywords

Beta blocker; Meta analysis; Mortality; Prostate cancer

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

EID: 84929405454     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S78836     Document Type: Article
Times cited : (53)

References (32)
  • 2
    • 84901400296 scopus 로고    scopus 로고
    • Analysis of the status and trends of prostate cancer incidence in China
    • Chinese
    • Han S, Zhang S, Chen W, et al. [Analysis of the status and trends of prostate cancer incidence in China]. Chin Clin Oncol. 2013;(04):330–334. Chinese.
    • (2013) Chin Clin Oncol , Issue.4 , pp. 330-334
    • Han, S.1    Zhang, S.2    Chen, W.3
  • 3
    • 84929396356 scopus 로고    scopus 로고
    • Analysis of the status and trends of prostate cancer mortality in China
    • Chinese
    • Han S, Zhang S, Chen W, et al. [Analysis of the status and trends of prostate cancer mortality in China]. Chin J Urol. 2012;33(11):836–839. Chinese.
    • (2012) Chin J Urol , vol.33 , Issue.11 , pp. 836-839
    • Han, S.1    Zhang, S.2    Chen, W.3
  • 4
    • 84888815889 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013
    • Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. part 1: Screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124–137.
    • (2014) Eur Urol , vol.65 , Issue.1 , pp. 124-137
    • Heidenreich, A.1    Bastian, P.J.2    Bellmunt, J.3
  • 5
    • 84857774190 scopus 로고    scopus 로고
    • Molecular pathways: Beta-adrenergic signaling in cancer
    • Cole SW, Sood AK. Molecular pathways: Beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18(5):1201–1206.
    • (2012) Clin Cancer Res , vol.18 , Issue.5 , pp. 1201-1206
    • Cole, S.W.1    Sood, A.K.2
  • 6
    • 77956931932 scopus 로고    scopus 로고
    • The sympathetic nervous system induces a metastatic switch in primary breast cancer
    • Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–7052.
    • (2010) Cancer Res , vol.70 , Issue.18 , pp. 7042-7052
    • Sloan, E.K.1    Priceman, S.J.2    Cox, B.F.3
  • 7
    • 84864418995 scopus 로고    scopus 로고
    • Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice
    • Campbell JP, Karolak MR, Ma Y, et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 2012;10(7):e1001363.
    • (2012) Plos Biol , vol.10 , Issue.7
    • Campbell, J.P.1    Karolak, M.R.2    Ma, Y.3
  • 8
    • 33746851955 scopus 로고    scopus 로고
    • Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
    • Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939–944.
    • (2006) Nat Med , vol.12 , Issue.8 , pp. 939-944
    • Thaker, P.H.1    Han, L.Y.2    Kamat, A.A.3
  • 9
    • 33646371479 scopus 로고    scopus 로고
    • The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers
    • Palm D, Lang K, Niggemann B, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer. 2006;118(11):2744–2749.
    • (2006) Int J Cancer , vol.118 , Issue.11 , pp. 2744-2749
    • Palm, D.1    Lang, K.2    Niggemann, B.3
  • 10
    • 84879685044 scopus 로고    scopus 로고
    • Beta-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
    • Pasquier E, Street J, Pouchy C, et al. Beta-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br J Cancer. 2013;108(12):2485–2494.
    • (2013) Br J Cancer , vol.108 , Issue.12 , pp. 2485-2494
    • Pasquier, E.1    Street, J.2    Pouchy, C.3
  • 11
    • 84893854541 scopus 로고    scopus 로고
    • Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
    • Wolter JK, Wolter NE, Blanch A, et al. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget. 2014;5(1):161–172.
    • (2014) Oncotarget , vol.5 , Issue.1 , pp. 161-172
    • Wolter, J.K.1    Wolter, N.E.2    Blanch, A.3
  • 12
    • 84858428443 scopus 로고    scopus 로고
    • Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: Implication in breast cancer treatment
    • Pasquier E, Ciccolini J, Carre M, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: Implication in breast cancer treatment. Oncotarget. 2011;2(10):797–809.
    • (2011) Oncotarget , vol.2 , Issue.10 , pp. 797-809
    • Pasquier, E.1    Ciccolini, J.2    Carre, M.3
  • 13
    • 84898702870 scopus 로고    scopus 로고
    • Therapeutic effect of beta-blockers in triple-negative breast cancer postmenopausal women
    • Botteri E, Munzone E, Rotmensz N, et al. Therapeutic effect of beta-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res Treat. 2013;140(3):567–575.
    • (2013) Breast Cancer Res Treat , vol.140 , Issue.3 , pp. 567-575
    • Botteri, E.1    Munzone, E.2    Rotmensz, N.3
  • 14
    • 84888876235 scopus 로고    scopus 로고
    • Effect of beta-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death
    • De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P. Effect of beta-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death. Mayo Clin Proc. 2013;88(11):1196–1203.
    • (2013) Mayo Clin Proc , vol.88 , Issue.11 , pp. 1196-1203
    • De Giorgi, V.1    Gandini, S.2    Grazzini, M.3    Benemei, S.4    Marchionni, N.5    Geppetti, P.6
  • 15
    • 84877125671 scopus 로고    scopus 로고
    • Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
    • Wang HM, Liao ZX, Komaki R, et al. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. 2013;24(5):1312–1319.
    • (2013) Ann Oncol , vol.24 , Issue.5 , pp. 1312-1319
    • Wang, H.M.1    Liao, Z.X.2    Komaki, R.3
  • 16
    • 84898049404 scopus 로고    scopus 로고
    • Stage-specific associations between beta blocker use and prognosis after colorectal cancer
    • Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H. Stage-specific associations between beta blocker use and prognosis after colorectal cancer. Cancer. 2014;120(8):1178–1186.
    • (2014) Cancer , vol.120 , Issue.8 , pp. 1178-1186
    • Jansen, L.1    Hoffmeister, M.2    Arndt, V.3    Chang-Claude, J.4    Brenner, H.5
  • 17
    • 79958717592 scopus 로고    scopus 로고
    • Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
    • Shah SM, Carey IM, Owen CG, Harris T, Dewilde S, Cook DG. Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol. 2011;72(1):157–161.
    • (2011) Br J Clin Pharmacol , vol.72 , Issue.1 , pp. 157-161
    • Shah, S.M.1    Carey, I.M.2    Owen, C.G.3    Harris, T.4    Dewilde, S.5    Cook, D.G.6
  • 18
    • 84872800402 scopus 로고    scopus 로고
    • Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
    • Grytli HH, Fagerland MW, Fossa SD, Tasken KA, Haheim LL. Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate. 2013;73(3):250–260.
    • (2013) Prostate , vol.73 , Issue.3 , pp. 250-260
    • Grytli, H.H.1    Fagerland, M.W.2    Fossa, S.D.3    Tasken, K.A.4    Haheim, L.L.5
  • 19
    • 84900521936 scopus 로고    scopus 로고
    • Beta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohort
    • Cardwell CR, Coleman HG, Murray LJ, O’Sullivan JM, Powe DG. Beta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohort. Cancer Epidemiol. 2014;38(3):279–285.
    • (2014) Cancer Epidemiol , vol.38 , Issue.3 , pp. 279-285
    • Cardwell, C.R.1    Coleman, H.G.2    Murray, L.J.3    O’Sullivan, J.M.4    Powe, D.G.5
  • 20
    • 84895064442 scopus 로고    scopus 로고
    • Association between use of beta-blockers and prostate cancer-specific survival: A cohort study of 3,561 prostate cancer patients with high-risk or metastatic disease
    • Grytli HH, Fagerland MW, Fossa SD, Tasken KA. Association between use of beta-blockers and prostate cancer-specific survival: A cohort study of 3,561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. 2014;65(3):635–641.
    • (2014) Eur Urol , vol.65 , Issue.3 , pp. 635-641
    • Grytli, H.H.1    Fagerland, M.W.2    Fossa, S.D.3    Tasken, K.A.4
  • 21
    • 0034685429 scopus 로고    scopus 로고
    • Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
    • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
    • (2000) JAMA , vol.283 , Issue.15 , pp. 2008-2012
    • Stroup, D.F.1    Berlin, J.A.2    Morton, S.C.3
  • 22
    • 0022992740 scopus 로고
    • Meta-analysis in clinical trials
    • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
    • (1986) Control Clin Trials , vol.7 , Issue.3 , pp. 177-188
    • Dersimonian, R.1    Laird, N.2
  • 23
    • 0037098199 scopus 로고    scopus 로고
    • Quantifying heterogeneity in a meta-analysis
    • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
    • (2002) Stat Med , vol.21 , Issue.11 , pp. 1539-1558
    • Higgins, J.P.1    Thompson, S.G.2
  • 24
    • 84925456716 scopus 로고    scopus 로고
    • Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer
    • Assayag J, Pollak MN, Azoulay L. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer. Eur J Cancer. 2014;50(16):2838–2845.
    • (2014) Eur J Cancer , vol.50 , Issue.16 , pp. 2838-2845
    • Assayag, J.1    Pollak, M.N.2    Azoulay, L.3
  • 25
    • 10744220803 scopus 로고    scopus 로고
    • Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines
    • Lutgendorf SK, Cole S, Costanzo E, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res. 2003;9(12):4514–4521.
    • (2003) Clin Cancer Res , vol.9 , Issue.12 , pp. 4514-4521
    • Lutgendorf, S.K.1    Cole, S.2    Costanzo, E.3
  • 26
    • 46149121727 scopus 로고    scopus 로고
    • Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis
    • Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15(7):2042–2052.
    • (2008) Ann Surg Oncol , vol.15 , Issue.7 , pp. 2042-2052
    • Benish, M.1    Bartal, I.2    Goldfarb, Y.3
  • 27
    • 84904113538 scopus 로고    scopus 로고
    • Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment
    • Kim-Fuchs C, Le CP, Pimentel MA, et al. Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun. 2014;40:40–47.
    • (2014) Brain Behav Immun , vol.40 , pp. 40-47
    • Kim-Fuchs, C.1    Le, C.P.2    Pimentel, M.A.3
  • 28
    • 84873358810 scopus 로고    scopus 로고
    • Behavioral stress accelerates prostate cancer development in mice
    • Hassan S, Karpova Y, Baiz D, et al. Behavioral stress accelerates prostate cancer development in mice. J Clin Invest. 2013;123(2):874–886.
    • (2013) J Clin Invest , vol.123 , Issue.2 , pp. 874-886
    • Hassan, S.1    Karpova, Y.2    Baiz, D.3
  • 29
    • 4043163432 scopus 로고    scopus 로고
    • Antihypertensive drug use and the risk of prostate cancer (Canada)
    • Perron L, Bairati I, Harel F, Meyer F. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control. 2004;15(6):535–541.
    • (2004) Cancer Causes Control , vol.15 , Issue.6 , pp. 535-541
    • Perron, L.1    Bairati, I.2    Harel, F.3    Meyer, F.4
  • 30
    • 82955212735 scopus 로고    scopus 로고
    • The association between antihypertensive drug use and incidence of prostate cancer in Finland: A population-based case-control study
    • Kemppainen KJ, Tammela TL, Auvinen A, Murtola TJ. The association between antihypertensive drug use and incidence of prostate cancer in Finland: A population-based case-control study. Cancer Causes Control. 2011;22(10):1445–1452.
    • (2011) Cancer Causes Control , vol.22 , Issue.10 , pp. 1445-1452
    • Kemppainen, K.J.1    Tammela, T.L.2    Auvinen, A.3    Murtola, T.J.4
  • 31
    • 84871180180 scopus 로고    scopus 로고
    • Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer
    • Mita AC, Figlin R, Mita MM. Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer. Clin Cancer Res. 2012;18(24):6574–6579.
    • (2012) Clin Cancer Res , vol.18 , Issue.24 , pp. 6574-6579
    • Mita, A.C.1    Figlin, R.2    Mita, M.M.3
  • 32
    • 84904658346 scopus 로고    scopus 로고
    • Taxanes in the management of metastatic castration-resistant prostate cancer: Efficacy and management of toxicity
    • Schutz FA, Buzaid AC, Sartor O. Taxanes in the management of metastatic castration-resistant prostate cancer: Efficacy and management of toxicity. Crit Rev Oncol Hematol. 2014;91(3):248–256.
    • (2014) Crit Rev Oncol Hematol , vol.91 , Issue.3 , pp. 248-256
    • Schutz, F.A.1    Buzaid, A.C.2    Sartor, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.